| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |